UPLC-Q-TOF-MS研究桃红四物汤治疗乳腺癌的作用机制
并在乳腺癌小鼠模型中观察桃红四物汤治疗后肿瘤病理变化及血清白细胞介素-4表达,结果显示桃红四物汤具有明显治疗作用,为其治疗乳腺癌提供物质基础。
要点
- 乳腺癌小鼠模型经桃红四物汤治疗后肿瘤病理及血清IL-4表达有变化。
- 桃红四物汤显示出明显治疗作用,为其乳腺癌应用提供物质基础。
核心结论
- 桃红四物汤在乳腺癌小鼠模型中具有明显治疗作用,该研究为其治疗乳腺癌提供了物质基础。
研究设计与样本
- 采用UPLC-Q-TOF-MS正负离子模式分析桃红四物汤水提物成分,并在乳腺癌小鼠模型中检测肿瘤病理变化及血清白细胞介素-4表达。
主要发现
- 桃红四物汤治疗后乳腺癌小鼠肿瘤病理变化及血清白细胞介素-4表达被检测,结果显示桃红四物汤有明显治疗作用。
关键数值与推荐
- 色谱柱为Waters ACQUITY UPLC BEH C18柱(2.1 mm×100 mm,1.7 μm),流动相为0.1%甲酸水溶液(A)和乙腈(B)。
临床怎么用
- 该研究为桃红四物汤用于乳腺癌治疗提供了成分和初步药效依据,但临床应用于乳腺癌仍需进一步研究验证。
局限性
- 原文未报告样本量、具体病理变化数值、白细胞介素-4表达水平及统计学检验结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Taohong Siwu decoction (THSWD) is a classic traditional Chinese medicine (TCM) prescription that is widely used in the clinical treatment of gynecological and cerebrovascular diseases. Here we used a method that coupled ultra-performance liquid chromatography to quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) in which both positive and negative ion modes were established to investigate the major constituents in THSWD. A Waters ACQUITY UPLC BEH C18 column (2.1 mm×100 mm, 1.7 μm) was used to separate the aqueous extract of THSWD. The mobile phase consisted of 0.1% aqueous formic acid (A) and acetonitrile (B). Ninety-five components were identified in two different ion modes, including aromatic acids, flavones, polysaccharides, volatile oils monoterpene glycosides, aromatic cyanogenic glycosides, and others. Pathological changes in tumors and serum expression of interleukin-4 in a mouse model of breast cancer were detected after THSWD treatment. The results showed that THSWD had obvious therapeutic effects. This study establishes a material basis for the use of THSWD in the treatment of breast cancer.
引用
- Duan X, Pan L, Bao Q, et al. UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment. Front Pharmacol. 2020. PMID: 32038266. doi:10.3389/fphar.2019.01625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。